Catherine Eckford2023-12-05T11:25:08
Currently, imetelstat is being reviewed by the FDA and EMA for the treatment of transfusion-dependent anaemia in adults with lower risk MDS.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-28T12:33:00Z
Sponsored by Gattefosse
2026-09-23T12:28:00Z
Sponsored by Pfizer CentreOne and Lubrizol Advanced Materials Europe BV, European Pharmaceutical Review
2026-09-23T09:00:00Z
Sponsored by Testo Saveris GmbH
2026-09-10T09:00:00Z
Sponsored by PCI Pharma Services, David O’Connell
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-07-13T07:00:00
Sponsored by Thermo Fisher Scientific
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-04-14T12:29:00
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-05-12T07:43:00
Sponsored by Sartorius, European Pharmaceutical Review
Site powered by Webvision Cloud